![](/img/cover-not-exists.png)
412PDesign and development of potent E1 ubiquitin activating enzyme inhibitor, CPL-410-005, as novel anticancer therapy
Stanczak, A., Górnicka, A., Stypik, B., Mroczkiewicz, M., Pieczykolan, J., Dubiel, K., Wieczorek, M.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx367.045
Date:
September, 2017
File:
PDF, 48 KB
english, 2017